These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 8651997)
1. [Stromal tumors of the digestive tract. Prognostic evaluation of a series of 36 cases]. Ghnassia JP; Wagner M; Velten M Ann Pathol; 1996; 16(1):27-32. PubMed ID: 8651997 [TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen immunoreactivity and prognosis of gastrointestinal stromal tumors. Franquemont DW; Frierson HF Mod Pathol; 1995 Jun; 8(5):473-7. PubMed ID: 7675763 [TBL] [Abstract][Full Text] [Related]
3. Stromal tumors of the stomach: prognostic value of the PCNA index. Ray R; Tahan SR; Andrews C; Goldman H Mod Pathol; 1994 Jan; 7(1):26-30. PubMed ID: 7909152 [TBL] [Abstract][Full Text] [Related]
4. [Prognostic significance of proliferation markers in hepatocellular carcinoma (HCC)]. Ebelt J; Neid M; Tannapfel A; Witzigmann H; Hauss J; Köckerling F; Wittekind C Zentralbl Chir; 2000; 125(7):597-601. PubMed ID: 10960968 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors. Can B; Sökmensüer C Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients. Iwasa Y; Haga H; Konishi I; Kobashi Y; Higuchi K; Katsuyama E; Minamiguchi S; Yamabe H Cancer; 1998 Feb; 82(3):512-9. PubMed ID: 9452269 [TBL] [Abstract][Full Text] [Related]
7. Stromal tumors of the digestive tract. Prognostic value of mitotic index. Moral Moral G; Gil Piedra F; Velasco Osés A; Seco Gil JL; de la Plaza Galindo M; Santamaría García JL Rev Esp Enferm Dig; 1998 May; 90(5):335-44. PubMed ID: 9656753 [TBL] [Abstract][Full Text] [Related]
8. The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors. Hu TH; Lin JW; Chen HH; Liu LF; Chuah SK; Tai MH Dis Colon Rectum; 2009 Feb; 52(2):319-26. PubMed ID: 19279430 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma. Tannapfel A; Geissler F; Köckerling F; Katalinic A; Hauss J; Wittekind C J Pathol; 1999 Mar; 187(4):439-45. PubMed ID: 10398104 [TBL] [Abstract][Full Text] [Related]
10. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors. Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575 [TBL] [Abstract][Full Text] [Related]
11. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients. Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047 [TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of prognostic indicators for sarcomas of the soft parts and the viscerae. Rudolph P; Bonichon F; Gloeckner K; Collin F; Chassevent A; Schmidt D; Coindre JM; Parwaresch R; Klöppel G Verh Dtsch Ges Pathol; 1998; 82():246-52. PubMed ID: 10095442 [TBL] [Abstract][Full Text] [Related]
13. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung. Demarchi LM; Reis MM; Palomino SA; Farhat C; Takagaki TY; Beyruti R; Saldiva PH; Capelozzi VL Mod Pathol; 2000 May; 13(5):511-20. PubMed ID: 10824922 [TBL] [Abstract][Full Text] [Related]
14. [New histopathologic data of prognostic value in extra-adrenal paragangliomas. Study of 9 cases]. García Rojo M; Martínez García C; Gamallo Amat C; Patrón Romero M Med Clin (Barc); 1993 Sep; 101(9):327-32. PubMed ID: 8105157 [TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma. Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009 [TBL] [Abstract][Full Text] [Related]
16. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma. Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in malignant gastrointestinal stromal tumors. Muro-Cacho CA; Cantor AB; Morgan M Ann Clin Lab Sci; 2000 Jul; 30(3):239-47. PubMed ID: 10945563 [TBL] [Abstract][Full Text] [Related]
20. [Adrenal cortical tumors. Prognostic evaluation of a series of 12 cases using anti-PCNA antibodies]. Ghnassia JP; Wagner M; Gasser B; Walter PR Ann Pathol; 1993; 13(5):312-6. PubMed ID: 7906124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]